Localization and interactions of melatonin in dry cholesterol/lecithin mixed reversed micelles used as cell membrane models

Journal of Pineal Research

Volumn 38, Issue 4, 2005, Pages 292-298

  Bongiorno, David ^a   Ceraulo, Leopoldo ^a,b   Ferrugia, Mirella ^a   Filizzola, Felice ^a   Ruggirello, Angela ^a   Liveri, Vincenzo Turco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Dipartimento di Chimica e Tecnologie Farmaceutiche   (Italy)

Author keywords

Cell membrane models; Cholesterol; Confinement effects; Lecithin; Melatonin; Reversed micelles

Indexed keywords

CARBON TETRACHLORIDE; CHOLESTEROL; MELATONIN; PHOSPHATIDYLCHOLINE;

ARTICLE; BINDING COMPETITION; CELL MEMBRANE; CELL MEMBRANE MODEL; CHOLESTEROL TO LECITHIN MOLAR RATIO; HYDROPHILICITY; INFRARED SPECTROSCOPY; MELATONIN TO LECITHIN MOLAR RATIO; MEMBRANE BINDING; MEMBRANE MODEL; MOLECULAR INTERACTION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSE MICELLE; SOLUBILIZATION; STOICHIOMETRY; BIOLOGICAL MODEL; CHEMISTRY; MICELLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CELL MEMBRANE; CHOLESTEROL; MAGNETIC RESONANCE SPECTROSCOPY; MELATONIN; MICELLES; MODELS, BIOLOGICAL; PHOSPHATIDYLCHOLINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 22844434840     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00211.x     Document Type: Article

References (32)

1. LERNER AB, CASE JD, TAKAHASHI Y et al. Isolation of melatonin the pineal gland factor that lightens the melanocytes. J Am Chem Soc 1958; 80:2587.
2. REITER RJ, CARNEIRO RCG, OH CS. Melatonin in relation to cellular defence mechanisms. Horm Metab Res 1997; 29:343-392.
3. TAN DX, CHEN LD, POEGGELER B et al. A potent endogenous hydroxyl radical scavenger. Endocrine J 1993; 1:57-60.
4. LIVREA MA, TESORIERE L, D'ARPA D et al. Reaction of melatonin with lipoperxyl radicals in phospholipid bilayers. Free Rad Biol Med 1997; 23:706-711.
5. MARSHALL KA, REITER RJ, POEGGELER B et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Rad Biol Med 1996; 21:307-315.
6. TURJANSKI AG, LEONIK F, ESTRIN DA et al. Scavenging of NO by melatonin. J Am Chem Soc 2000; 122:10468-10469.
7. 2: evidence for free radical mechanism. J Am Chem Soc 1999; 121:9738-9739.
8. DE VRIES MW, PEETERS FP. Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression. J Nerv Ment Dis 1997; 185:201-202.
9. JAN JE, O'DONNELL ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21:193-199.
10. GARFINKEL D, LAUDON M, NOF D, ZISAPEL N. Improvement of sleep quality in elderly people by controlled release melatonin. Lancet 1995; 346:541-544.
11. REITER RJ. Melatonin: that ubiquitously acting pineal hormone. News Physiol Sci 1991; 6:223-227.
12. BARRET P, CONWAY S, MORGAN PJ. Digging deep-structure-function relationship in the melatonin receptor family. J Pineal Res 2003; 35:221-230.
13. LISSONI P, BARNI S, BRIVIO F et al. A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenya. Oncology 1995; 52:360-362.
14. LISSONI P, MEREGALLI S, NOSETTO L et al. Increased survival time in brain glioblastomas by a radioneuroendocrine stategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 1996; 53:43-46.
15. LISSONI P, CHILELLI M, CERIZZA S et al. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003; 35:12-15.
16. MAESTRONI GJ. Melatonin regulation of endogenous T-cell derived hematopoietic cytokines. Cancer Res 1994; 54:2429-2432.
17. ZHOU JN, LIU RY, KAMPHORST W et al. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 2003; 35:125-130.
18. PAPPOLLA MA, REITER RJ, BRYANT-THOMAS TK. Oxidative mediated neurodegeneration in Alzheimer's disease: melatonin and related antioxidants as neuroprotective agents. Curr Med Chem 2003; 3:233-243.
19. ABE M, REITER RJ, POEGGELER B. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994; 17:94-100.
20. TAN DX, MANCHESTER LC, SAINZ R, MAYO JL et al. Antioxidant strategies in protection against neurodegenerative disorders. Expert Opin Ther Patents 2003; 13:1513-1543.
21. CARDINALI DP, LADIEZESKY MG, BOGGIO V et al. Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res 2003; 34:81-87.
22. CHEUNG TF. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34:153-160.
23. SAHNA E, ACET A, OZER MK et al. Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supple-mental physiological doses of melatonin. J Pineal Res 2002; 33:234-238.
24. TURCO-LIVERI V. From dilute to concentrate solution of reversed micelles. Curr Topics Sol Chem 1997; 2:143-156.
25. LUISI PL, GIOMINI M, PILENI MP et al. Reverse micelles as hosts for proteins and small molecules. Biochim Biophys Acta 1988; 947:209-246.
26. CERAULO L, FERRUGIA M, TESORIERE L et al. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles. J Pineal Res 1999; 26:108-112.
27. BONGIORNO D, CERAULO L, FERRUGIA M et al. 1H-NMR and FT-IR study of the state of melatonin confined in membrane models: location and interactions of melatonin in water free lecithin and AOT reversed micelles. Arkivoc 2004; part (v):251-262.
28. CERAULO L, DORMOND E, MELE A et al. FT-IR and nuclear Overhauser enhancement study of the state of urea confined in AOT-reversed micelles. Colloids Surfaces A 2003; 218:255-264.
29. TEMSAMANI MB, HAECK M, EL HASSANI I et al. Fourier transform infrared investigation of water states in aerosol-OT reverse micelles as a function of counterionic nature. J Phys Chem B 1998; 102:3335-3340.
30. REITER RJ, TAN DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58:10-19.
31. HOYOS M, GUERRERO JM, PEREZ-CANO R et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000; 28:150-155.
32. SEWERYNEK E. Melatonin and the cardiovascular system. Neuroendocrinol Lett 2002; 23(Suppl. 1):79-83.